摘要
目的探讨纤维支气管镜(纤支镜)在支气管结核(EBTB)治疗中的应用价值。方法173例经纤支镜确诊的支气管结核患者随机分为治疗组(76例)和对照组(97例),治疗组在常规抗结核化疗基础上,每周经纤支镜对病变部位介入治疗1、2次。对照组仅用常规治疗。2个月为一疗程,治疗前后观察比较,治疗后1年内定期复查。结果疗程结束治疗组肺不张由术前45例降至9例,张力空洞从15例降至1例,痰阴转为84.4%;对照组肺不张由47例降至33例,张力空洞由17例降至12例,痰阴转62.1%,治疗组较对照组有明显好转(P<0.01)。
To explore the value of bronchofiberoscope in the treatment of endobronchial tuberculosis (EBTB). 173 patients with biopsy-proven EBTB were randomly divided into treatment group (76 patients) and control group (97 patients). In addition to regular anti-tuberculosis chemotherapy, the treatment group was treated by bronchofiberoscope on lesions once or twice a week, the control group was only treated by regular chemotherapy. Two months were one period of treatment. To compare the effeciency before and after treatment and check regularly in a year after treatment. 45 cases of atelactasis decreased to 9 at the end of treatment period. 15 cases of strain inanition decreased to 1. 84.4% of positive sputum examinations before treatment became negative. While in control group, 47 cases of atelactasis decreased to 33 and 17 cases of stain inanition decreased to 12,only 62.1% of positive sputum examinations became negative. The treatment group was significantly better compared with control group (P <0.01). [Conclusions] Treatment by bronchofiberoscope is a better way treating endobronchial tuberculosis at present.
出处
《中国内镜杂志》
CSCD
北大核心
2005年第1期43-44,共2页
China Journal of Endoscopy
关键词
纤维支气管镜
介入治疗
支气管结核
bronchofiberoscope
treatment
endobronchial tuberculosis
